Orchestra BioMed Inc.
5.48
0.21 (3.98%)
At close: Jan 15, 2025, 1:42 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20
PE Ratio -6.18 -4.45 -8.96 -12.27
PS Ratio 109.91 42.34 -263.6 45.93
PB Ratio 4.46 2.85 -2.89 -5.4
P/FCF Ratio -6.57 -5.01 -10.46 -9.8
P/OCF Ratio -6.58 -5.11 -10.61 -10.01
OCF/S Ratio -16.71 -8.29 24.85 -4.59
Debt / Equity Ratio 0.02 0.23 -0.08 -0.19
Quick Ratio 7.94 4.55 0.92 2.52
Current Ratio 7.95 4.56 0.92 2.52
Asset Turnover 0.03 0.04 -0.06 0.15
Interest Coverage n/a n/a -23.52 n/a
Return on Equity (ROE) -0.72 -0.64 0.32 0.44
Return on Assets (ROA) -0.52 -0.35 -1.7 -0.56
Return on Capital (ROIC) -0.61 -0.42 -16.94 -0.79
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin 93.26% 90.89% 125.45% 97.46%
Net Profit Margin -1.78K% -951.26% 2.94K% -374.45%
Pretax Profit Margin -1.78K% -951.26% 2.94K% -374.45%
Operating Profit Margin -1.87K% -924.34% 2.79K% -328.81%
FCF Margin -1.67K% -845.74% 2.52K% -468.56%
EBITDA Margin -1.86K% -918.06% 2.76K% -326.41%